UAB researchers developed a novel RNA-based molecular test that more accurately distinguishes active C. diff infection from ...

Nurse-driven protocol can be adapted to other units, authors say ...

Mice fed a high-fat, high-protein diet were more likely to develop and die from antibiotic-driven Clostridioides difficile infections than mice fed a standard diet. In the same study, a ...

This year in review of 2025 milestones in Clostridioides difficile infection features coverage of research on infection patterns presented at the American Society for Microbiology Microbe 2025 meeting ...

A new study from the University of Birmingham has shown that fecal microbiota transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C. diff) infection. A new ...

Clostridioides difficile infection (CDI) happens when C. diff bacteria multiply in the gut, producing toxins that damage the colon which cause watery diarrhea, abdominal pain, and inflammation.

Clostridium difficile is a Gram-positive spore-forming bacteria that is a normal component of the colon flora in humans. It can cause antibiotic-associated diarrhea (ADD) when competing bacteria in ...

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff). University of Exeter researchers first identified a gene in C. diff ...

In a recent study published in Microbiology, researchers demonstrate that Clostridioides difficile spores exposed to sodium hypochlorite solutions at clinically relevant concentrations remained viable ...

In a recent review published in BMC Infectious Diseases, researchers reviewed existing data on Clostridioides difficile infections (CDI) among United States residents. CDIs have caused considerable ...

Clostridioides difficile is a notoriously nasty intestinal bug, with few effective treatments and no approved vaccines. But the same technology that enabled the first COVID-19 vaccines has shown early ...